Search for: "F&G Research, Inc. v. Creative Technology Limited"
Results 1 - 20
of 24
Sort by Relevance
|
Sort by Date
13 Feb 2023, 7:54 am
Random House, Inc. [read post]
24 Mar 2021, 2:10 am
In ‘Rambus Inc. v. [read post]
24 Mar 2021, 2:10 am
In ‘Rambus Inc. v. [read post]
5 Dec 2017, 12:01 pm
Morton David Goldberg, Cowan, Liebowitz & Latman, New York, New York, for amici Alliance Entertainment Corp., Audible Inc., Blue Spike, Inc., The Clandestine Group, Inc., Digimarc Corporation, Digital Media on Demand, Inc., FullAudio Corporation, InterTrust Technologies Corporation, Oak Technology, Inc., Reciprocal, Inc., RioPort, Inc., RPK SecureMedia Inc., Verance Corporation, and VNU USA, Inc. [read post]
2 Jan 2017, 12:18 pm
Rogers Communications Inc., 2011 BCSC 1196. [read post]
28 Dec 2015, 2:51 am
The court found that the piece in question, a review of anti-counterfeit regulations, “possesses a creative quality, epitomised by originality and novelty” because the work was "“the result of a personal, original, new and creative elaboration of legal concepts and industry practices and of the experiences of the author”. [read post]
5 Jan 2014, 3:30 pm
ASCAP[12] and Video Pipeline, Inc. v. [read post]
12 Sep 2011, 3:35 am
(IPBiz) US Patents – Decisions CAFC reverses DNH in Markem-Imaje Corporation v Zipher; Newman partially dissents (IPBiz) District Court Nevada: Plaintiff need not produce licenses involving unasserted patents where licenses involving patents-in-suit have been produced: Bally Technologies, Inc. v. [read post]
23 Feb 2011, 4:02 pm
This seems to me an important area in which research and creative thinking is needed. [read post]
28 Apr 2010, 10:51 am
Cir. 2001); View Eng'g, Inc. v. [read post]
15 Mar 2010, 2:09 pm
pid=20601103&sid=a9SowGrPI4JM, Keane, Angela G., U.S. [read post]
8 Dec 2009, 5:26 pm
" Exxon Research & Eng'g Co. v. [read post]
16 Sep 2009, 1:47 pm
(Holyoke, MA; Kathleen Macy, President) Applied Predictive Technologies, Inc. [read post]
17 Aug 2009, 10:44 am
Tile, Inc. [read post]
15 Jun 2009, 3:00 am
– ‘Rioja’ GI survives (Class 46) Suriname Impersonator acquitted of attempting to deceive paying customers into thinking she is the true Toni Braxton (1709 Copyright Blog) Switzerland Some data on 3D trademarks in Switzerland (Class 46) Shapes that made it, and those that didn’t (Class 46) United Kingdom EWHC: Revocation proceedings not an abuse of process even if not commercially justified: TNS Group Holdings Ltd v Neilsen Media… [read post]
15 Jun 2009, 3:00 am
– ‘Rioja’ GI survives (Class 46) Suriname Impersonator acquitted of attempting to deceive paying customers into thinking she is the true Toni Braxton (1709 Copyright Blog) Switzerland Some data on 3D trademarks in Switzerland (Class 46) Shapes that made it, and those that didn’t (Class 46) United Kingdom EWHC: Revocation proceedings not an abuse of process even if not commercially justified: TNS Group Holdings Ltd v… [read post]
9 Jan 2009, 7:00 am
: G-Star v Pepsico (Class 46) Nigeria Nigeria celebrates 20 years of copyright law (Afro-IP) Poland Confusion around ARENDA (Class 46) Inspiration or plagiarism? [read post]
13 Oct 2008, 12:12 pm
ECJ clarifies rules relating to notice: K-Swiss Inc v OHIM (Class 46) EU Competitiveness Council resolution against counterfeiting and piracy (Class 46) EU states back three-point anti-piracy plan (Managing Intellectual Property) Fuel cells and wind power lead European patent filings for clean energy technology (Green Patent Blog) More non-minor geographical indicator (GI) amendments published (Class 46) No sign of any Community patent progress, despite Verheugen's… [read post]
29 Aug 2008, 1:00 pm
The curiously chameleonic properties of data ownershipImage Protein models by Alan Wolf.Used under a Creative Commons BY-NC-CA 2.0 license. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by… [read post]
